Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 1;19(8):888-895.
doi: 10.6004/jnccn.2021.0038.

NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021

Nadeem R Abu-Rustum  1 , Catheryn M Yashar  2 , Kristin Bradley  3 , Susana M Campos  4 , Junzo Chino  5 , Hye Sook Chon  6 , Christina Chu  7 , David Cohn  8 , Marta Ann Crispens  9 , Shari Damast  10 , Elisabeth Diver  11 , Christine M Fisher  12 , Peter Frederick  13 , David K Gaffney  14 , Suzanne George  4 , Robert Giuntoli  15 , Ernest Han  16 , Brooke Howitt  11 , Warner K Huh  17 , Jayanthi Lea  18 , Andrea Mariani  19 , David Mutch  20 , Larissa Nekhlyudov  4 , Mirna Podoll  9 , Steven W Remmenga  21 , R Kevin Reynolds  22 , Ritu Salani  23 , Rachel Sisodia  24 , Pamela Soliman  25 , Edward Tanner  26 , Stefanie Ueda  27 , Renata Urban  28 , Stephanie L Wethington  29 , Emily Wyse  30 , Kristine Zanotti  31 , Nicole R McMillian  32 , Angela D Motter  32
Affiliations

NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021

Nadeem R Abu-Rustum et al. J Natl Compr Canc Netw. .

Abstract

The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid in accurate diagnosis, classification, and treatment of uterine sarcomas.

PubMed Disclaimer

LinkOut - more resources